Ocular Therapeutix, Inc. (OCUL)
NASDAQ: OCUL · Real-Time Price · USD
8.78
-0.14 (-1.57%)
Nov 20, 2024, 4:00 PM EST - Market open
Ocular Therapeutix Market Cap
Ocular Therapeutix has a market cap or net worth of $1.38 billion as of November 21, 2024. Its market cap has increased by 530.02% in one year.
Market Cap
1.38B
Enterprise Value
1.03B
1-Year Change
530.02%
Ranking
Category
Stock Price
$8.78
Market Cap Chart
Since July 25, 2014, Ocular Therapeutix's market cap has increased from $270.50M to $1.38B, an increase of 410.30%. That is a compound annual growth rate of 17.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2024 | 1.40B | 295.93% |
| Dec 29, 2023 | 354.20M | 63.68% |
| Dec 30, 2022 | 216.40M | -59.48% |
| Dec 31, 2021 | 534.00M | -63.87% |
| Dec 31, 2020 | 1.48B | 678.20% |
| Dec 31, 2019 | 189.90M | 16.08% |
| Dec 31, 2018 | 163.60M | 24.89% |
| Dec 29, 2017 | 131.00M | -37.08% |
| Dec 30, 2016 | 208.20M | -10.18% |
| Dec 31, 2015 | 231.80M | -53.78% |
| Dec 31, 2014 | 501.50M | 85.40% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Intellia Therapeutics | 1.44B |
| Evolent Health | 1.40B |
| Bicycle Therapeutics | 1.39B |
| Spyre Therapeutics | 1.38B |
| Harrow | 1.37B |
| Schrödinger | 1.37B |
| ARS Pharmaceuticals | 1.37B |
| Myriad Genetics | 1.37B |